Browsing: FDA

AstraZeneca’s potential first-in-class aldosterone inhibitor could help millions with hard-to-control high blood pressure. Global biopharmaceutical company AstraZeneca announced that the…

FDA greenlights early-stage trial of VectorY’s first-in-class therapy targeting the core biology driving most ALS cases. Netherlands-based biotech VectorY Therapeutics…

Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration…

Novo Nordisk has filed for FDA approval of a higher-dose Wegovy injection, backed by strong trial data and a national…

Regulatory scrutiny from the Federal Trade Commission (FTC), National Advertising Division (NAD) and the Food and Drug Administration (FDA) has…

The non-profit organization used the release of its Strategic Roadmap and Action Plan to advocate for changes to the Food…

uniQure’s “game changing” data announced in September, which showed significant slowing of Huntington’s disease (HD) progression in patients treated with…

Credit: hapabapa / Editorial RF / iStock Editorial / Getty Images Plus Thymidine kinase 2 deficiency (TK2d) is an ultra-rare…

uniQure has acknowledged that what it called “game changing” data in September showing significant slowing of Huntington’s disease (HD) progression…

People with memory or thinking changes who are worried they have Alzheimer’s disease can get an answer sooner thanks to…